Abivax (AAVXF) Other Working Capital Changes (2024 - 2026)

Abivax has reported Other Working Capital Changes for 3 years, with the latest figure at -$482347.2 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 99.37% year-over-year to -$482347.2 in Q1 2026; TTM through Mar 2026 was -$1.1 billion, a 116.68% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 116.68% from the prior year.
• Other Working Capital Changes was -$482347.2 for Q1 2026 at Abivax, up from -$1.1 billion in the prior quarter.
• The five-year high for Other Working Capital Changes was $79.0 million in Q4 2024, with the low at -$75.8 million in Q4 2025.
• Average Other Working Capital Changes over 3 years is $383160.9, with a median of $37867.8 recorded in 2025.
• The largest YoY upside for Other Working Capital Changes was 55.73% in 2025 against a maximum downside of 173.73% in 2025.
• Over 3 years, Other Working Capital Changes stood at -$489.0 million in 2024, then plunged by 116.68% to -$1.1 billion in 2025, then jumped by 99.95% to -$482347.2 in 2026.
• The last three Other Working Capital Changes figures came in at -$482347.2 (Q1 2026), -$1.1 billion (Q4 2025), and -$378773.8 (Q3 2025), per Business Quant data.